Skip to main content
Duke University Libraries
Search 
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • Search
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • Search
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-2 of 2

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Returns to R&D on new drug introductions in the 1980s. 

    Grabowski, Henry G; Vernon, John M (J Health Econ, 1994-12)
    This study finds that the mean IRR for 1980-84 U.S. new drug introductions is 11.1%, and the mean NPV is 22 million (1990 dollars). The distribution of returns is highly skewed. The results are robust to plausible changes ...
    Thumbnail

    Cost of innovation in the pharmaceutical industry. 

    DiMasi, Joseph A; Grabowski, Henry G; Hansen, Ronald W; Lasagna, L (J Health Econ, 1991-07)
    The research and development costs of 93 randomly selected new chemical entities (NCEs) were obtained from a survey of 12 U.S.-owned pharmaceutical firms. These data were used to estimate the pre-tax average cost of new ...
     

     

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CollectionAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Discover

    Author
    Grabowski, Henry G (2)
    DiMasi, Joseph A (1)Hansen, Ronald W (1)Lasagna, L (1)Vernon, John M (1)Date Issued1991 (1)1994 (1)TypeJournal article (2)SubjectCosts and Cost Analysis (2)
    Data Collection (2)
    Drug Industry (2)United States (2)Commerce (1)Data Interpretation, Statistical (1)Drug Evaluation (1)Drug Evaluation, Preclinical (1)Drugs, Investigational (1)Health Policy (1)... View MoreAffiliation of Duke Author(s)Duke (2)Economics (2)Trinity College of Arts & Sciences (2)